Tradestie Institutional Equity Comparison Engine

CSTL vs NDRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CSTL Overall Edge

CSTL Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Castle Biosciences, Inc. Common Stock (CSTL) driven by superior Momentum & Technical, Options & Structure while NDRA counters with relative strength in Growth & Margin. Fundamentally, CSTL trades at N/M Forward P/E with -7.4% operating margin (+23.9% YoY revenue) versus NDRA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CSTL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against NDRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CSTL N/M vs NDRA N/M Fwd P/E
Growth & Margin Winner NDRA
Op Margin -7.4% vs 0.0% ยท YoY +23.9% vs +0.0%
Momentum & Technical Winner CSTL
1Y -4.0% vs -32.7% ยท 52W Pos 57% vs 37%
Options & Structure Winner CSTL
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
CSTL NASDAQ
Castle Biosciences, Inc. Common Stock
Services-Medical Laboratories
$32.75
-3.08% 1D
Market Cap $1.0B
1M Return +2.47%
1Y Return -4.02%
Forward P/E N/M
Unified AI Score
49.3 / 100 HOLD
Tech 25.0 Fund 41.0 Flow 50.0 Mom 54.0
NDRA NASDAQ
ENDRA Life Sciences Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.42
+0.23% 1D
Market Cap $6.6M
1M Return -6.75%
1Y Return -32.72%
Forward P/E N/M
Unified AI Score
44.7 / 100 HOLD
Tech 35.0 Fund 46.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CSTL -4.02% NDRA -32.72% Spread: +28.7 pp (CSTL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CSTL TTM Op. Margin: -7.4% NDRA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CSTL vs NDRA. Trailing 12-month operating profitability (CSTL -7.4% vs NDRA 0.0%) and valuation multiples (CSTL N/M vs NDRA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CSTL (5) vs NDRA (3)
Institutional Metric CSTL NDRA Criterion Row Winner
Market Capitalization Scale $1.0B $6.6M Larger Scale CSTL
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +23.9% +0.0% Higher Growth CSTL
Operating Margin (TTM) Profitability -7.4% 0.0% Higher Margin NDRA
Net Profit Margin Profitability -6.1% 0.0% Higher Margin NDRA
Return on Equity (ROE) Capital Efficiency -4.9% -152.0% Higher ROE CSTL
52-Week Range Position Momentum 57% ($18โ€“$44) 37% ($3โ€“$7) Stronger Trend CSTL
Beta / 30D Volatility Risk Regime 1.18ฮฒ ยท 57% Vol 0.71ฮฒ ยท 48% Vol Lower Realized Risk NDRA
Unified Institutional Score Composite Signal 49.3 / 100 (HOLD) 44.7 / 100 (HOLD) Higher Composite CSTL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CSTL vs NDRA Buy Guide
CSTL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live CSTL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NDRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NDRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CSTL nor NDRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.